AI Score
Our AI model analyzes fundamental, technical, and statistical indicators
to predict the probability of a bullish trend over the next three months.
We regularly update and refine our models to deliver the most reliable forecasts
for you.
Bullish Probability | Sentiment | Score |
---|---|---|
+80% | Strong Buy | 10 |
+75% | Buy | 9 |
+70% | Buy | 8 |
+60% | Buy | 7 |
+50% | Hold | 6 |
+45% | Hold | 5 |
+40% | Hold | 4 |
+35% | Sell | 3 |
+30% | Sell | 2 |
+20% | Strong Sell | 1 |
Company Description
Envoy Medical, Inc., a hearing health company, provides medical technologies for the hearing loss spectrum.
Its products include personal sound amplification devices; hearing aids; Esteem fully implanted active middle ear implants; auditory osseointegrated implants; and Acclaim cochlear implants.
The company was formerly known as Envoy Medical Corporation and changed its name to Envoy Medical, Inc. in September 2023.
Envoy Medical, Inc. was founded in 1995 and is headquartered in White Bear Lake, Minnesota.
Country | United States |
IPO Date | n/a |
Industry | Medical - Specialties |
Sector | Healthcare |
Employees | 34 |
CEO | Brent T. Lucas Esq. |
Contact Details
Address: 4875 White Bear Parkway White Bear Lake, Minnesota United States | |
Website | https://www.envoymedical.com |
Stock Details
Ticker Symbol | COCHW |
Exchange | NASDAQ |
Fiscal Year | January - December |
Reporting Currency | USD |
CIK Code | 0001840877 |
CUSIP Number | 29415V117 |
ISIN Number | US29415V1171 |
Employer ID | 86-1369123 |
SIC Code | 6770 |
Key Executives
Name | Position |
---|---|
Brent T. Lucas Esq. | Chief Executive Officer & Director |
David R. Wells | Chief Financial Officer |
Karin Simonson | Vice President, General Counsel & Corporate Secretary |
Latest SEC Filings
Date | Type | Title |
---|---|---|
Dec 26, 2024 | SCHEDULE 13D | Filing |
Dec 26, 2024 | 4 | Filing |
Dec 26, 2024 | 4 | Filing |
Dec 23, 2024 | 424B3 | Filing |
Dec 23, 2024 | 8-K | Current Report |
Dec 20, 2024 | 424B3 | Filing |
Dec 20, 2024 | 8-K | Current Report |
Dec 17, 2024 | 4 | Filing |
Dec 17, 2024 | 424B3 | Filing |
Dec 17, 2024 | 8-K | Current Report |